219
Views
6
CrossRef citations to date
0
Altmetric
Drug Discovery Case History

Lenvatinib for thyroid cancer treatment: discovery, pre-clinical development and clinical application

, , , , &
Pages 11-26 | Received 06 Jun 2019, Accepted 26 Sep 2019, Published online: 13 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Siddharth J. Modi & Vithal M. Kulkarni. (2022) Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, ‘DFG-out’ inhibitors. Journal of Biomolecular Structure and Dynamics 40:12, pages 5712-5727.
Read now
Pietro Locantore, Roberto Novizio, Andrea Corsello, Rosa Maria Paragliola, Alfredo Pontecorvi & Salvatore Maria Corsello. (2022) Discovery, preclinical development, and clinical application of pralsetinib in the treatment of thyroid cancer. Expert Opinion on Drug Discovery 17:2, pages 101-107.
Read now
Silvia Martina Ferrari, Giusy Elia, Francesca Ragusa, Sabrina Rosaria Paparo, Valeria Mazzi, Mario Miccoli, Maria Rosaria Galdiero, Gilda Varricchi, Rudy Foddis, Giovanni Guglielmi, Claudio Spinelli, Concettina La Motta, Salvatore Benvenga, Alessandro Antonelli & Poupak Fallahi. (2021) Lenvatinib: an investigational agent for the treatment of differentiated thyroid cancer. Expert Opinion on Investigational Drugs 30:9, pages 913-921.
Read now

Articles from other publishers (3)

Sushanta Bhattacharya, Vivek Asati, Amena Ali, Abuzer Ali & G.D. Gupta. (2022) In-silico studies for the development of novel RET inhibitors for cancer treatment. Journal of Molecular Structure 1251, pages 132040.
Crossref
Naga Rajiv Lakkaniga, Naresh Gunaganti, Lingtian Zhang, Binyam Belachew, Brendan Frett, Yuet-Kin Leung & Hong-yu Li. (2020) Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 206, pages 112691.
Crossref
Mohammad Al-Jundi, Shilpa Thakur, Sriram Gubbi & Joanna Klubo-Gwiezdzinska. (2020) Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review. Cancers 12:8, pages 2104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.